Platelet-derived endothelial cell growth factor thymidine phosphorylase in tumour growth and response to therapy.
about
Thymidine phosphorylase expression in normal and hyperplastic endometriumStructures of native human thymidine phosphorylase and in complex with 5-iodouracilKinetic analysis of novel multisubstrate analogue inhibitors of thymidine phosphorylase.Clinical significance of angiogenic factors in breast cancer.Glycation of glutamate cysteine ligase by 2-deoxy-d-ribose and its potential impact on chemoresistance in glioblastoma.The hemostatic system and angiogenesis in malignancy.Significance of platelet count in esophageal carcinomasAlteration of nucleotide metabolism: a new mechanism for mitochondrial disorders.Clinical implications of angiogenesis in cancers.Correlation of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase with sensitivity of gastrointestinal cancer cells to 5-fluorouracil and 5-fluoro-2'-deoxyuridineTumour markers of prognosis in colorectal cancer.Thymidine phosphorylase/platelet-derived endothelial cell growth factor is upregulated in advanced solid types of gastric cancerExpression of angiogenic factors predicts response to chemoradiotherapy and prognosis of oesophageal squamous cell carcinomaMitochondrial neurogastrointestinal encephalomyopathy (MNGIE): biochemical features and therapeutic approaches.Vascular changes in hepatocellular carcinoma.Molecular targeted therapy of advanced hepatocellular carcinoma beyond sorafenib.Thymidine phosphorylase expression in normal, hyperplastic and neoplastic prostates: correlation with tumour associated macrophages, infiltrating lymphocytes, and angiogenesis.Thymidine phosphorylase, dihydropyrimidine dehydrogenase and thymidylate synthase mRNA expression in primary colorectal tumors-correlation to tumor histopathology and clinical follow-up.Structural basis for non-competitive product inhibition in human thymidine phosphorylase: implications for drug designImpacts of Early Life Stress on the Methylome and Transcriptome of Atlantic Salmon.The metabolic interactions between tumor cells and tumor-associated stroma (TAS) in prostatic cancer.Increased cytotoxicity and bystander effect of 5-fluorouracil and 5-deoxy-5-fluorouridine in human colorectal cancer cells transfected with thymidine phosphorylase.Phase 1-2 trial of PTK787/ZK222584 combined with intravenous doxorubicin for treatment of patients with advanced hepatocellular carcinoma: implication for antiangiogenic approach to hepatocellular carcinoma.Concurrent expression of angiogenic growth factors and neovascularization during tumourigenesis in colorectal carcinoma patients.Prognostic value of thymidine phosphorylase expression in breast carcinoma.Prognostic significance of serum thymidine phosphorylase concentration in esophageal squamous cell carcinoma.An investigation of the kinetic and anti-angiogenic properties of plant glycoside inhibitors of thymidine phosphorylase.Quantitative Platelet Abnormalities in Patients With Hepatitis B Virus-Related Liver Disease.Thrombocytosis and Raised CRP Levels Predicts Advanced Stage in Esophageal Carcinoma.Impact of serum biomarkers on esophageal squamous cell carcinoma
P2860
Q24682942-201A7D01-8DE1-46D3-8BFA-02C25517ED91Q27646320-3A9EAA53-4DD0-461F-8A63-284F652853C9Q31480237-D2860E5E-FA48-4455-9847-5A906D28ED53Q33538444-60BF03A7-1BDA-4933-8161-3437EEA37647Q34037091-B148A6CA-84D3-4B9F-A517-F8F29128C280Q34425462-77DA3916-E253-424C-BC6C-390141C10F4AQ34996025-A3082894-32AF-49F0-924B-AF460E2ED6D8Q35206509-E0664156-41EF-4998-BC71-A08F3B78841EQ36012979-CF1F7065-5178-4BEE-837C-3CCBE92940C9Q36474351-EEA67552-0843-43DD-A996-4FA64D42DE4AQ36617345-C730AECE-1953-46B3-8DE5-2699178A08D0Q36617535-8C0E0E06-9735-48C7-9794-6C3E291A5510Q36644051-8A6F05CC-B245-4EAD-AF3F-16E0D88D6B8EQ36840779-AF218DCA-69AA-4E48-A518-C7306632390AQ37165456-A120EC86-D3A2-4E27-B655-DF45D0580507Q37779804-88465A78-D6C6-4AE6-8FB7-872DC4895A89Q38283244-B71136CE-30F8-4ACD-B954-6C6B75F61EA1Q38441178-27A0F96F-119C-4741-933A-FA027A3295B8Q38663123-809DAC84-D278-44F6-8FF1-6B66658D5C79Q39257719-2D537CA2-1BE2-48C8-96BD-52C9A0D1EEC5Q41334614-E9FD3AB2-440B-4A05-9FD4-19373823C0EEQ41897991-9F2B32C9-BC53-4998-A28B-B404D5CFBC0AQ42971014-0531815C-346D-4732-A307-EAEC41673B75Q43773753-9F9500A3-F179-4CE9-87E0-767AB94E9505Q43861068-D7F2ED46-2B84-4239-803A-56A2E116D198Q43947296-427738C5-6813-41E1-B087-974CA2C3231DQ46120975-855D4613-F621-426C-8F9B-ADA9923F8EDAQ47142999-87E8A6FD-8F6D-4EBC-AE06-5BAD9F7760C7Q52928949-A96A832C-474C-476F-A6A4-C38BE58A4E43Q57707731-CD134679-6350-4DD9-801E-6B5C38E6F7CE
P2860
Platelet-derived endothelial cell growth factor thymidine phosphorylase in tumour growth and response to therapy.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Platelet-derived endothelial c ...... rowth and response to therapy.
@en
type
label
Platelet-derived endothelial c ...... rowth and response to therapy.
@en
prefLabel
Platelet-derived endothelial c ...... rowth and response to therapy.
@en
P2860
P921
P356
P1476
Platelet-derived endothelial c ...... rowth and response to therapy.
@en
P2093
I J Stratford
L Griffiths
P2860
P2888
P304
P356
10.1038/BJC.1997.447
P407
P577
1997-01-01T00:00:00Z